CYTORUM
Private Company
Funding information not available
Overview
Cytorum is a specialized contract research organization (CRO) providing high-parameter single-cell analysis services to the biopharma industry. Leveraging cutting-edge cytometry platforms—including spectral fluorescence and mass cytometry (CyTOF)—the company designs and executes complex assays for drug discovery, biomarker identification, and preclinical studies. By combining technical expertise in panel design and sample processing with sophisticated data analytics, Cytorum positions itself as a critical partner for clients navigating the complexities of immunology, immuno-oncology, and cell therapy development. The company operates a full-service lab in Silicon Valley, California, offering an end-to-end solution from project conception to data interpretation.
Technology Platform
Multi-platform single-cell analysis suite featuring fluorescence cytometry (up to 18 parameters), spectral cytometry (25+ parameters), and mass cytometry/CyTOF (40+ parameters). Complementary capabilities include cell sorting, tissue culture, lab automation, custom antibody conjugation, and an informatics pipeline for data analysis and visualization.
Opportunities
Risk Factors
Competitive Landscape
Cytorum competes in the specialized flow cytometry CRO space against firms like Precision for Medicine (Cellularity), Q2 Solutions, and numerous regional/specialty labs. It also faces indirect competition from in-house pharma labs and academic core facilities. Differentiation is achieved through a multi-platform approach, deep assay development expertise, and a strong focus on data analytics and interpretation.